Austin-Zimmerman, Isabelle http://orcid.org/0000-0002-3428-5070
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Giannakopoulou, Olga
Deak, Joseph D. http://orcid.org/0000-0002-0540-6080
Galimberti, Marco http://orcid.org/0000-0001-6052-156X
Adhikari, Keyrun http://orcid.org/0000-0001-9129-1699
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Denaxas, Spiros
Irizar, Haritz
Kuchenbaecker, Karoline http://orcid.org/0000-0001-9726-603X
McQuillin, Andrew http://orcid.org/0000-0003-1567-2240
,
Concato, John
Buysse, Daniel J.
Gaziano, J. Michael
Gottlieb, Daniel J.
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Bramon, Elvira http://orcid.org/0000-0003-1369-5983
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Funding for this research was provided by:
U.S. Department of Veterans Affairs (I01CX001849)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (T32 AA028259)
Marie Sklodowska-Curie grant agreement
Article History
Received: 16 August 2022
Accepted: 28 August 2023
First Online: 28 September 2023
Competing interests
: D.J.B. has served as a paid or unpaid consultant to the National Cancer Institute, Pear Therapeutics, Sleep Number, Idorsia, Eisai, and Weight Watchers International. All consulting agreements have been for a total of <$5000 per year from any single entity. D.J.B. is an author of the Pittsburgh Sleep Quality Index, Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A), Brief Pittsburgh Sleep Quality Index (B-PSQI), Daytime Insomnia Symptoms Scale, Pittsburgh Sleep Diary, Insomnia Symptom Questionnaire, and RU_SATED (copyrights held by University of Pittsburgh). These instruments have been licensed to commercial entities for fees. He is also co-author of the Consensus Sleep Diary (copyright held by Ryerson University), which is licensed to commercial entities for a fee. He has received grant support from NIH, PCORI, AHRQ, VA and Sleep Number. D.J.G. reports participation on Scientific Advisory Boards for Signifier Medical Technologies, Inc., Wesper, Inc., and Powell-Mansfield, Inc., outside of the submitted work. R.P. is paid for his editorial work in the journal Complex Psychiatry and received a research grant outside the scope of this study from Alkermes. M.B.S. has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Biogen, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sage Therapeutics, Sumitomo Pharma, and Roche/Genentech. Dr. Stein has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, the Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. J.G. is paid for editorial work for the journal Complex Psychiatry. The remaining authors declare no competing interests.